VIR - Vir Biotechnology, Inc.
9.1
-0.460 -5.055%
Share volume: 2,457,741
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$9.56
-0.46
-0.05%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-26-2025 | 05-07-2025 | 11-05-2025 | 02-23-2026 | |
| Cash flow financing | 1.263 M | 598.000 K | 102.000 K | 1.039 M | |
| Other financing cash flows | 267.000 K | 598.000 K | 101.000 K | 1.000 K | |
| Cash flow | 54.365 M | 49.300 M | -127.022 M | 61.814 M | |
| Net income | -104.589 M | -120.965 M | -163.141 M | -42.923 M | |
| Depreciation | 2.886 M | 2.867 M | 2.998 M | 2.898 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 140.737 M | 126.818 M | 40.446 M | 86.651 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -48.000 K | 1.348 M | 280.000 K | 458.000 K | |
| Cash Change | 54.365 M | 49.300 M | -127.022 M | 61.814 M |